Shenzhen Salubris Pharmaceuticals Co., Ltd. (SZSE:002294) said it cuts share private placement size to CNY 1.98 billion ($302.50 million) from CNY 2.0 billion. The company said it plans to spin off biomedical engineering unit for listing in domestic stock exchange.